Artwork

Indhold leveret af CRC Group. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af CRC Group eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

The Skinny on GLP-1s for Healthcare Industry Risks

24:44
 
Del
 

Manage episode 445801726 series 2822097
Indhold leveret af CRC Group. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af CRC Group eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to resumes@crcgroup.com today!

  continue reading

Kapitler

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

92 episoder

Artwork
iconDel
 
Manage episode 445801726 series 2822097
Indhold leveret af CRC Group. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af CRC Group eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to resumes@crcgroup.com today!

  continue reading

Kapitler

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

92 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning